Professor Kefah Mokbel currently serves as the Chair of Breast Cancer Surgery at the London Breast Institute, part of HCA Healthcare UK.
London, UK
Joined September 2009
- Tweets2.2K
- Following5
- Followers1.1K
- Likes21
Our message during October
linkedin.com/posts/professor…
Our latest publication mdpi.com/2072-6694/18/18/298…
Based on current evidence, minimally invasive nipple-sparing mastectomy should presently be regarded as a selective approach rather than a universal standard in breast cancer surgery.
tbcr.amegroups.org/article/v…
OneMark™ represents a novel attempt to re-engineer breast localisation by integrating diagnosis and surgical guidance into a single step. Its principal innovation lies in pathway efficiency rather than incremental improvements in localisation technology tbcr.amegroups.org/article/v…
ALND after neoadjuvant chemotherapy: a call for caution - The Lancet Oncology thelancet.com/journals/lanon…
Axillary Lymph Node Dissection Is Not Routinely Indicated in Patients with Sentinel Lymph Node Residual Micrometastases Following Neoadjuvant Systemic Therapy - The American Journal of Surgery americanjournalofsurgery.com…
Our recently published editorial Modern management of phyllodes tumours: closing the gap between evidence and practice gs.amegroups.org/article/vie…
I would like to share our editorial published today reflecting on the B-51 trial:
The subtype-specific signals—potential detriment in TNBC, possible benefit in HR-positive disease—reveal that de-escalation is not a one-size-fits-all proposition
tcr.amegroups.org/article/vi…
Our latest article tbcr.amegroups.org/article/v…
Selective elimination of surgery for early invasive breast cancer: promise, challenges, and prospects gs.amegroups.org/article/vie…
The B-51 trial has delivered high-quality evidence supporting the safe omission of RNI in selected patients (cT1–3N1M0, HER2+ or TNBC) with nodal pCR after NAC. gs.amegroups.org/article/vie…
Adjuvant CDK4/6 inhibitors for early breast cancer & MonarchE update tcr.amegroups.org/article/vi…
I would like to share our latest publication reflecting on the recently published B-51 clinical trial:
gs.amegroups.org/article/vie…
Is post mastectomy radiation therapy a contraindication to immediate breast reconstruction at the time of mastectomy?
No
Methodological considerations in evaluating reconstructive strategies following postmastectomy radiotherapy - Wazir - Gland Surgery gs.amegroups.org/article/vie…
Selective elimination of surgery for early invasive breast cancer: promise, challenges, and prospects - Venkataraman - Gland Surgery gs.amegroups.org/article/vie…
Limitations and oncological uncertainties of intraductal laser ablation for pathological nipple discharge - Rizk - Translational Cancer Research tcr.amegroups.org/article/vi…
gs.amegroups.org/article/vie… Selective elimination of surgery for early invasive breast cancer: promise, challenges, and prospects - Venkataraman - Gland Surgery
